HK1199451A1 - Substituted quinary aza heterocyclic salt compound and its uses in therapeutic protein aging-related disease - Google Patents

Substituted quinary aza heterocyclic salt compound and its uses in therapeutic protein aging-related disease

Info

Publication number
HK1199451A1
HK1199451A1 HK14113096.0A HK14113096A HK1199451A1 HK 1199451 A1 HK1199451 A1 HK 1199451A1 HK 14113096 A HK14113096 A HK 14113096A HK 1199451 A1 HK1199451 A1 HK 1199451A1
Authority
HK
Hong Kong
Prior art keywords
related disease
therapeutic protein
salt compound
protein aging
heterocyclic salt
Prior art date
Application number
HK14113096.0A
Other languages
Chinese (zh)
Inventor
李松
崔浩
肖軍海
鍾武
王莉莉
程罡
Original Assignee
Beijing Molecule Science And Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beijing Molecule Science And Technology Co Ltd filed Critical Beijing Molecule Science And Technology Co Ltd
Publication of HK1199451A1 publication Critical patent/HK1199451A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
    • A23L3/34—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals
    • A23L3/3454—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals in the form of liquids or solids
    • A23L3/3463—Organic compounds; Microorganisms; Enzymes
    • A23L3/3544—Organic compounds containing hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/24—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK14113096.0A 2006-01-27 2014-12-31 Substituted quinary aza heterocyclic salt compound and its uses in therapeutic protein aging-related disease HK1199451A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410332231.2A CN104151261B (en) 2006-01-27 2006-01-27 Five-membered nitrogen heterocyclic ring substituted salt compound and application thereof in treating protein aging related diseases

Publications (1)

Publication Number Publication Date
HK1199451A1 true HK1199451A1 (en) 2015-07-03

Family

ID=51876922

Family Applications (1)

Application Number Title Priority Date Filing Date
HK14113096.0A HK1199451A1 (en) 2006-01-27 2014-12-31 Substituted quinary aza heterocyclic salt compound and its uses in therapeutic protein aging-related disease

Country Status (2)

Country Link
CN (1) CN104151261B (en)
HK (1) HK1199451A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT808163E (en) * 1995-01-18 2003-12-31 Alteon Inc USE OF TIAZOLIUM COMPOUNDS FOR PREVENTION AND REVERSAL OF THE FORMATION OF FINAL PRODUCTS WITH ADVANCED GLYCOSILACA
WO2004092134A1 (en) * 2003-04-15 2004-10-28 Warner-Lambert Company Llc [c]-fused bicyclic proline derivatives and their use for treating arthritic conditions

Also Published As

Publication number Publication date
CN104151261A (en) 2014-11-19
CN104151261B (en) 2017-02-15

Similar Documents

Publication Publication Date Title
HK1199874A1 (en) Spiro-oxindole compounds and their uses as therapeutic agents
GB0625659D0 (en) Therapeutic compounds and their use
IL186615A0 (en) Spiroheterocylic compounds and their uses as therapeutic agents
IL195400A0 (en) Aldh-2 inhibitors in the treatment of addiction
IL195346A0 (en) Novel heterocyclic compound or salt thereof and intermediate thereof
PT1978947E (en) Nitrooxyderivatives for use in the treatment of muscular dystrophies
HK1136822A1 (en) Therapeutic compounds and their use in cancer
EP1962961A4 (en) Demibodies: dimerisation-activated therapeutic agents
GB0523576D0 (en) Drug composition and its use in therapy
PL2101731T3 (en) Endoxifen for use in the treatment of cancer
GB0506835D0 (en) Therapeutic use of nefopam
HK1151241A1 (en) Enhancement of the efficacy of therapeutic proteins
PL2012805T3 (en) Therapeutic composition and use
BRPI0714318A2 (en) USE OF 2-BENZOIL-IMIDAZOPYRIDINS IN THERAPEUTIC
IL193663A0 (en) Thiadiazole compounds and their use in phototherapy
GB0622479D0 (en) Novel salts and their therapeutic use
EP2109936A4 (en) Multiple polarity reversible charge pump circuit and related methods
GB0515703D0 (en) Therapeutic use of nefopam
HK1199451A1 (en) Substituted quinary aza heterocyclic salt compound and its uses in therapeutic protein aging-related disease
IL185575A0 (en) Benzoxazocines and their therapeutic use
PT2240200T (en) Therapeutic mannan linked mylein basic protein peptide mbp83-99
GB0505203D0 (en) Skin composition treatment
GB0614538D0 (en) Therapeutic Compounds And Their Use
ZA200808072B (en) Heterocyclic compounds and their use in the treatment of cardiovascular disease
GB0625633D0 (en) Therapeutic compounds and their use

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20220125